Page last updated: 2024-08-21

2,3-dimethylmaleic anhydride and Experimental Neoplasms

2,3-dimethylmaleic anhydride has been researched along with Experimental Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, H; Han, K; Wang, S; Xu, L; Zhang, C; Zhang, J; Zhang, W; Zhang, X1
Hirano, T; Kamada, H; Kaneda, Y; Mayumi, T; Tsunoda, S; Tsutsumi, Y; Yamamoto, Y1

Other Studies

2 other study(ies) available for 2,3-dimethylmaleic anhydride and Experimental Neoplasms

ArticleYear
Tumor-Triggered Geometrical Shape Switch of Chimeric Peptide for Enhanced in Vivo Tumor Internalization and Photodynamic Therapy.
    ACS nano, 2017, 03-28, Volume: 11, Issue:3

    Topics: Animals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; HeLa Cells; Humans; Hydrogen-Ion Concentration; Maleic Anhydrides; Mice; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Particle Size; Peptides; Photochemotherapy; Photosensitizing Agents; Structure-Activity Relationship; Surface Properties; Tumor Microenvironment

2017
Bioconjugation of tumor necrosis factor-alpha with the copolymer of divinyl ether and maleic anhydride increasing its antitumor potency.
    Biochemical and biophysical research communications, 1997, Oct-09, Volume: 239, Issue:1

    Topics: Animals; Antineoplastic Agents; Body Weight; Chromatography, Gel; Humans; Maleic Anhydrides; Mice; Models, Chemical; Neoplasms, Experimental; Platelet Count; Pyran Copolymer; Tumor Necrosis Factor-alpha

1997